Talbot Financial LLC Increases Holdings in Stryker Co. (NYSE:SYK)

Talbot Financial LLC increased its stake in shares of Stryker Co. (NYSE:SYK) by 2.9% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 44,426 shares of the medical technology company’s stock after purchasing an additional 1,269 shares during the period. Stryker accounts for 2.0% of Talbot Financial LLC’s investment portfolio, making the stock its 15th largest position. Talbot Financial LLC’s holdings in Stryker were worth $16,049,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. Cape ANN Savings Bank boosted its position in shares of Stryker by 10.7% in the third quarter. Cape ANN Savings Bank now owns 2,126 shares of the medical technology company’s stock valued at $768,000 after acquiring an additional 206 shares during the period. Reliant Investment Management LLC boosted its holdings in Stryker by 0.9% in the 3rd quarter. Reliant Investment Management LLC now owns 15,200 shares of the medical technology company’s stock valued at $5,491,000 after purchasing an additional 138 shares during the period. Sugarloaf Wealth Management LLC grew its position in shares of Stryker by 32.7% during the 3rd quarter. Sugarloaf Wealth Management LLC now owns 446 shares of the medical technology company’s stock valued at $161,000 after purchasing an additional 110 shares in the last quarter. Atomi Financial Group Inc. raised its position in shares of Stryker by 2.3% in the third quarter. Atomi Financial Group Inc. now owns 2,091 shares of the medical technology company’s stock worth $755,000 after buying an additional 47 shares in the last quarter. Finally, Dynamic Advisor Solutions LLC boosted its stake in Stryker by 2.3% during the third quarter. Dynamic Advisor Solutions LLC now owns 2,990 shares of the medical technology company’s stock valued at $1,080,000 after buying an additional 67 shares during the period. Institutional investors own 77.09% of the company’s stock.

Insider Transactions at Stryker

In related news, VP M Kathryn Fink sold 2,121 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $370.00, for a total value of $784,770.00. Following the transaction, the vice president now owns 10,042 shares in the company, valued at $3,715,540. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, insider Viju Menon sold 600 shares of the company’s stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $355.00, for a total transaction of $213,000.00. Following the transaction, the insider now directly owns 9,069 shares of the company’s stock, valued at $3,219,495. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP M Kathryn Fink sold 2,121 shares of Stryker stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $370.00, for a total value of $784,770.00. Following the completion of the sale, the vice president now owns 10,042 shares of the company’s stock, valued at $3,715,540. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 220,068 shares of company stock valued at $71,811,372. Insiders own 5.90% of the company’s stock.

Analysts Set New Price Targets

SYK has been the topic of a number of research analyst reports. UBS Group upped their target price on Stryker from $351.00 to $366.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 31st. Needham & Company LLC lifted their target price on shares of Stryker from $392.00 to $393.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. BTIG Research increased their price target on shares of Stryker from $360.00 to $374.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. Evercore ISI lifted their price objective on shares of Stryker from $365.00 to $380.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $386.00 target price on shares of Stryker in a research note on Wednesday, July 31st. Four investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Stryker has an average rating of “Moderate Buy” and a consensus target price of $379.37.

Stryker Stock Performance

Shares of SYK stock opened at $350.81 on Wednesday. The company’s fifty day moving average price is $350.01 and its 200-day moving average price is $342.93. The stock has a market cap of $133.64 billion, a PE ratio of 40.05, a price-to-earnings-growth ratio of 2.71 and a beta of 0.91. The company has a current ratio of 1.68, a quick ratio of 0.95 and a debt-to-equity ratio of 0.51. Stryker Co. has a 12 month low of $249.98 and a 12 month high of $374.63.

Stryker (NYSE:SYK) last announced its earnings results on Tuesday, July 30th. The medical technology company reported $2.81 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.02. Stryker had a net margin of 16.12% and a return on equity of 22.89%. The business had revenue of $5.42 billion during the quarter, compared to the consensus estimate of $5.40 billion. During the same quarter last year, the firm earned $2.54 earnings per share. The business’s revenue for the quarter was up 8.5% on a year-over-year basis. On average, equities analysts expect that Stryker Co. will post 12 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Monday, September 30th will be paid a $0.80 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.91%. Stryker’s dividend payout ratio is currently 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.